Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1994 Oct;38(10):2510–2512. doi: 10.1128/aac.38.10.2510

Oral absorption of ofloxacin administered together with aluminum.

A Sánchez Navarro 1, M Martínez Cabarga 1, A Dominguez-Gil Hurlé 1
PMCID: PMC284776  PMID: 7840600

Abstract

A clinical study was carried out to establish the influence of aluminum on the oral absorption of ofloxacin. Ten healthy volunteers were included in a crossover study based on a Latin square design. The treatments that all volunteers received were A, consisting of 400 mg of ofloxacin, and B, consisting of 400 mg of ofloxacin plus 11 g of colloidal aluminum phosphate. The absorption constant and other ofloxacin parameters were calculated from data on levels in plasma by using model-independent calculation methods. There were no statistically significant differences between the mean values of the areas under the curve corresponding to the administration of ofloxacin alone and those of ofloxacin with aluminum. Regarding the other pharmacokinetic parameters, a significant difference between the absorption constants was found. The presence of aluminum reduces the absorption rate of this quinolone but does not modify the percentage of the absorbed dose.

Full text

PDF
2510

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Campbell N. R., Kara M., Hasinoff B. B., Haddara W. M., McKay D. W. Norfloxacin interaction with antacids and minerals. Br J Clin Pharmacol. 1992 Jan;33(1):115–116. doi: 10.1111/j.1365-2125.1992.tb04010.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Flor S., Guay D. R., Opsahl J. A., Tack K., Matzke G. R. Effects of magnesium-aluminum hydroxide and calcium carbonate antacids on bioavailability of ofloxacin. Antimicrob Agents Chemother. 1990 Dec;34(12):2436–2438. doi: 10.1128/aac.34.12.2436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Frost R. W., Lasseter K. C., Noe A. J., Shamblen E. C., Lettieri J. T. Effects of aluminum hydroxide and calcium carbonate antacids on the bioavailability of ciprofloxacin. Antimicrob Agents Chemother. 1992 Apr;36(4):830–832. doi: 10.1128/aac.36.4.830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Grasela T. H., Jr, Schentag J. J., Sedman A. J., Wilton J. H., Thomas D. J., Schultz R. W., Lebsack M. E., Kinkel A. W. Inhibition of enoxacin absorption by antacids or ranitidine. Antimicrob Agents Chemother. 1989 May;33(5):615–617. doi: 10.1128/aac.33.5.615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Maesen F. P., Davies B. I., Geraedts W. H., Sumajow C. A. Ofloxacin and antacids. J Antimicrob Chemother. 1987 Jun;19(6):848–850. doi: 10.1093/jac/19.6.848. [DOI] [PubMed] [Google Scholar]
  6. Martínez Cabarga M., Sánchez Navarro A., Colino Gandarillas C. I., Domínguez-Gil A. Effects of two cations on gastrointestinal absorption of ofloxacin. Antimicrob Agents Chemother. 1991 Oct;35(10):2102–2105. doi: 10.1128/aac.35.10.2102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Neuman M. Clinical pharmacokinetics of the newer antibacterial 4-quinolones. Clin Pharmacokinet. 1988 Feb;14(2):96–121. doi: 10.2165/00003088-198814020-00003. [DOI] [PubMed] [Google Scholar]
  8. Nix D. E., Watson W. A., Lener M. E., Frost R. W., Krol G., Goldstein H., Lettieri J., Schentag J. J. Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin. Clin Pharmacol Ther. 1989 Dec;46(6):700–705. doi: 10.1038/clpt.1989.207. [DOI] [PubMed] [Google Scholar]
  9. Nix D. E., Wilton J. H., Ronald B., Distlerath L., Williams V. C., Norman A. Inhibition of norfloxacin absorption by antacids. Antimicrob Agents Chemother. 1990 Mar;34(3):432–435. doi: 10.1128/aac.34.3.432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Wolfson J. S., Hooper D. C. Comparative pharmacokinetics of ofloxacin and ciprofloxacin. Am J Med. 1989 Dec 29;87(6C):31S–36S. [PubMed] [Google Scholar]
  11. Yamaoka K., Nakagawa T. A nonlinear least squares program based on differential equations, MULTI (RUNGE), for microcomputers. J Pharmacobiodyn. 1983 Aug;6(8):595–606. doi: 10.1248/bpb1978.6.595. [DOI] [PubMed] [Google Scholar]
  12. Yamaoka K., Nakagawa T., Uno T. Statistical moments in pharmacokinetics. J Pharmacokinet Biopharm. 1978 Dec;6(6):547–558. doi: 10.1007/BF01062109. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES